Pharma & Biotech

Akari Therapeutics experienced significant price volatility following the company's latest move to strengthen its intellectual property portfolio. The biopharmaceutical firm...

NRX Pharmaceuticals experienced a dramatic sell-off on Friday, with its stock price collapsing by nearly 11% to close at $3.17....

While Ocuphire Pharma's stock celebrates a spectacular rally, reaching new annual peaks with a stunning 50% surge over the past...

Rockwell Medical's stock continues its relentless downward trajectory, with Friday's trading session delivering another devastating blow to shareholder value. The...

FibroGen's stock continued its downward trajectory on Friday, closing at $10.55 after declining 3.74% during the trading session. This latest...

Adicet Bio's stock demonstrated significant strength in Friday's trading session, climbing 5.80% to reach $0.97 per share. This upward movement...

Investors in IGC Pharma have delivered a powerful endorsement of the company's leadership and strategic direction. During yesterday's annual general...

The corporate identity of Allovir Inc. has been formally retired. A significant merger transaction with Kalaris Therapeutics, finalized in March...

Precision BioSciences Inc shares are demonstrating significant upward momentum, fueled by substantial advancements in its proprietary gene-editing platform. Recent scientific...

Swiss biopharmaceutical firm Idorsia Ltd has successfully concluded a capital increase that exceeded initial expectations, demonstrating robust market confidence. The...